Regenerative Orthopedics & PRP: Advancing Beyond Cosmetic Peels

August 28, 2025

Regenerative Orthopedics & PRP: Advancing Beyond Cosmetic Peels

Introduction

Platelet-rich plasma (PRP) is widely known in aesthetic medicine for facial rejuvenation and hair restoration, but it is also used in musculoskeletal care for conditions involving joints, tendons, and ligaments. PRP is made from a patient’s own blood and delivers a concentrated platelet preparation to a targeted area. Research has shown that it can improve pain and function in certain conditions. When combined with stem cell therapies, it may help alleviate pain, support tissue repair, improve long-term function, and potentially delay or reduce the need for surgical intervention. In this article, we’ll explore the science behind PRP and stem-cell–based orthopedics, review common procedures, discuss clinical evidence, and provide practical guidance for integrating these therapies into a personalized rehabilitation plan.

The Science of PRP & Stem Cells

Platelet-Rich Plasma: A Growth-Factor Cocktail

PRP is typically prepared by centrifuging a patient’s anticoagulated blood to create a platelet-enriched plasma fraction. Platelets contain alpha granules with signaling molecules involved in wound healing, inflammation, angiogenesis, and extracellular-matrix remodeling.

  • Platelet-Derived Growth Factor (PDGF): Supports cell migration, proliferation, and tissue-repair signaling.
  • Transforming Growth Factor-β (TGF-β): Helps modulate inflammation and extracellular-matrix production.
  • Vascular Endothelial Growth Factor (VEGF): Supports blood-vessel formation.
  • Insulin-Like Growth Factor-1 (IGF-1): Participates in cell-growth and repair signaling.

Upon injection into injured tissue, these factors orchestrate a coordinated repair response: macrophage recruitment, stem-cell activation, angiogenesis, and matrix remodeling.

Mesenchymal Stem Cells (MSCs): Building Blocks of Repair

MSCs are multipotent progenitor cells found in bone marrow, adipose tissue, and perinatal tissues. Their reparative actions include:

  1. Differentiation Potential: MSCs can differentiate into chondrocyte-, osteoblast-, and tenocyte-like cells under specific culture conditions.
  2. Paracrine Signaling: MSCs release a broad range of bioactive molecules, including cytokines, growth factors, and extracellular vesicles. Factors such as IL-10 and TSG-6 have been associated with anti-inflammatory, antifibrotic, and pro-repair signaling.
  3. Immune Modulation: MSCs can interact with immune cells, including T cells and macrophages, and may promote a less pro-inflammatory, more pro-resolution environment.

Combining PRP with MSCs creates a synergistic environment: PRP’s growth factors kick-start repair and guide MSC differentiation, while MSCs sustain immunomodulation and matrix regeneration over weeks to months.

Clinical Applications & Evidence

Tendinopathies & Ligament Injuries

  • Lateral Epicondylitis (Tennis Elbow): PRP may provide longer-lasting symptom improvement in patients with chronic lateral elbow tendinopathy, with some studies demonstrating greater improvements in pain and function over time compared with corticosteroid injections. When combined with bone marrow–derived MSCs, treatment may also support tendon healing, collagen organization, and tissue quality, potentially further improving long-term function.
  • Achilles Tendinopathy: PRP may help reduce pain and support tendon healing in patients with chronic Achilles tendinopathy. When combined with bone marrow-derived MSCs, some studies suggest additional improvements in pain, tendon recovery, and return to activity compared with PRP alone..

Osteoarthritis (OA) of the Knee

  • PRP Alone: Multiple meta-analyses demonstrate knee PRP injections may improve pain and function for some patients over several months.
  • PRP + MSCs: Adding bone marrow-derived MSCs may further reduce inflammation, support tissue repair, and provide greater, longer-lasting symptom relief, potentially helping to delay the need for joint replacement in some patients.

Spinal Disc & Facet Joint Regeneration

  • Discogenic Back Pain: Intradiscal PRP has been evaluated in small studies, demonstrating potential pain relief and a generally favorable safety profile. When combined with bone marrow-derived MSCs, treatment may further support glycosaminoglycan production, disc hydration, tissue integrity, and overall function.
  • Facet Arthropathy: Evidence for PRP in facet-mediated pain is still emerging, but early studies suggest it may help reduce pain and improve function. Combining PRP with bone marrow-derived MSCs and injecting them directly into the affected facet joints under ultrasound guidance may provide more sustained relief from axial back pain while supporting joint tissue recovery compared with corticosteroid injections.

Procedural Protocols

PRP Preparation & Injection

  1. Blood Draw & Centrifugation:
    • Draw 30–60 mL of peripheral blood.
    • Single- or double-spin protocols yield 3–6 mL of PRP with 3–8× baseline platelet concentration.
    • NOTE: Blood volume and preparation methods vary by system, target tissue, and clinician protocol.
  2. Activation:
    • Some protocols use calcium chloride or other activation methods, while others inject PRP without exogenous activation.
  3. Guided Delivery:
    • Ultrasound is commonly used to guide tendon, ligament, and joint injections.
    • Fluoroscopy may be used for certain spine procedures when clinically appropriate.
  4. Post-Injection Care:
    • Advise relative activity modification for the first 48 hours, followed by a gradual, diagnosis-specific rehabilitation program focused on restoring movement, building strength, and progressively increasing tissue loading.

Cell-Based Procedures

  • Autologous Bone-Marrow Aspirate Concentrate (BMAC):
    • Derived from a patient’s bone marrow and contains a heterogeneous cell population
    • Aspirate 60–120 mL from posterior iliac crest; centrifuge to concentrate MSCs and growth factors.

Practical Considerations & Patient Selection

  • PRP may be worth discussing with an orthopedic, sports-medicine, or physical-medicine clinician for patients with:
  • Chronic tendinopathy that has not responded adequately to a structured rehabilitation program
  • Mild-to-moderate knee osteoarthritis that remains symptomatic despite conservative care
  • Selected partial tendon or ligament injuries where surgical repair is not yet indicated

Contraindications and Precautions

  • Suitability depends on the individual patient, procedure, and product used. Potential reasons to defer or modify treatment can include:
    • Active local or systemic infection
    • Significant bleeding risk, platelet disorders, or use of certain anticoagulant or antiplatelet medications
    • Uncontrolled medical conditions
    • Suspicion for malignancy or another diagnosis

Conclusion & Call to Action

Regenerative orthopedics uses therapies such as PRP, bone marrow-derived cells, and supportive peptides to enhance the body’s natural repair processes. By addressing inflammation, supporting tissue healing, and promoting extracellular matrix remodeling, these approaches may help reduce pain, improve mobility and function, and potentially delay or avoid more invasive interventions in appropriately selected patients.

Whether you’re dealing with a chronic tendon injury, joint pain, or early osteoarthritis, treatment can be tailored to your specific condition, imaging, and goals.

Ready to explore your options? Book a consultation with Dr. Seeds to review your condition and determine whether PRP, bone marrow-derived therapies, or a combination approach may be appropriate for you.